Ischemic stroke (IS) is still one of the major issues in medicine. Still, early diagnosis and misdiagnosis remain the main barriers for proper patient treatment and follow-up. Exploring new potential diagnostic biomarkers for IS is relevant to decrease patient morbidity and the occurrence of poststroke diseases. Biomedical analysis could bring new light to the background of IS and—in such a way—propose new bioanalytical tools for the early diagnosis, prognostication, and monitoring of IS.

Read More...

Leave a comment.

Your email address will not be published. Required fields are marked*

Andoird App
Loading...